Both in Pharmaceuticals
Ligand Pharmaceuticals vs Amneal Pharmaceuticals
Over the past year LGND returned +63.9% and AMRX returned +80.5%; their daily moves had a correlation of 0.29.
LGND +63.9% AMRX +80.5%Growth of $1, one year, split-adjusted
| Metric | LGND | AMRX |
|---|---|---|
| Price | $313.52 | $20.21 |
| Market cap | $6.27B | $7.04B |
| Today | +2.12% | −1.13% |
| 1 month | +2.2% | −0.7% |
| 6 months | +35.0% | +50.7% |
| Year to date | +65.8% | +60.4% |
| 1 year | +63.9% | +86.8% |
| Revenue growth (YoY) | −31.8% | +9.9% |
| Gross margin | 83.7% | 42.0% |
| Net margin | −36.2% | 7.2% |
| P/E (TTM) | 121.9× | 44.7× |
| Price / sales | 24.7× | 2.3× |
| Net cash | -$653.3M | -$2.54B |
| Dividend yield | — | — |
| Volatility (60d) | 29.7% | 39.1% |
| Short % of float | 13.3% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).